Publication Rhodesia Jackson 5/11/23 Publication Rhodesia Jackson 5/11/23 ALETA-001, a CAR-T Engager protein, or CTE, optimizes anti-CD19 CAR-T celltherapies for lymphoma Read More Publication Rhodesia Jackson 4/28/19 Publication Rhodesia Jackson 4/28/19 A CD19-Anti-ErbB2 scFv Engager Protein EnablesCD19-Specific CAR T Cells to Eradicate ErbB2+ Solid Cancer Read More Publication Rhodesia Jackson 4/28/19 Publication Rhodesia Jackson 4/28/19 CAR T Engager proteins optimize anti CD19 CAR T cell therapies for lymphoma Read More Publication Rhodesia Jackson 4/27/19 Publication Rhodesia Jackson 4/27/19 Anti-CD19 CAR T cells potently redirected to kill solid tumor cells Read More Publication Rhodesia Jackson 4/26/19 Publication Rhodesia Jackson 4/26/19 Anti-CD19 CAR T Cells That Secrete a Biparatopic Anti-CLEC12A Bridging Protein Have Potent Activity Against Highly Aggressive Acute Myeloid Leukemia In Vitro and In Vivo Read More
Publication Rhodesia Jackson 5/11/23 Publication Rhodesia Jackson 5/11/23 ALETA-001, a CAR-T Engager protein, or CTE, optimizes anti-CD19 CAR-T celltherapies for lymphoma Read More
Publication Rhodesia Jackson 4/28/19 Publication Rhodesia Jackson 4/28/19 A CD19-Anti-ErbB2 scFv Engager Protein EnablesCD19-Specific CAR T Cells to Eradicate ErbB2+ Solid Cancer Read More
Publication Rhodesia Jackson 4/28/19 Publication Rhodesia Jackson 4/28/19 CAR T Engager proteins optimize anti CD19 CAR T cell therapies for lymphoma Read More
Publication Rhodesia Jackson 4/27/19 Publication Rhodesia Jackson 4/27/19 Anti-CD19 CAR T cells potently redirected to kill solid tumor cells Read More
Publication Rhodesia Jackson 4/26/19 Publication Rhodesia Jackson 4/26/19 Anti-CD19 CAR T Cells That Secrete a Biparatopic Anti-CLEC12A Bridging Protein Have Potent Activity Against Highly Aggressive Acute Myeloid Leukemia In Vitro and In Vivo Read More
